National Cancer Institute
dccps logo
Epidemiology and Genetics Research Branch
Cancer Control and Population Sciences

About the Program:

EGRP’s Four Branches


Methods and Technologies Branch

 
Mukesh Verma
Mukesh Verma, Ph.D.
Branch Chief
The Methods and Technologies Branch (MTB) focuses on methods to address epidemiologic data collection, study design and analysis, and to modify technological approaches developed in the context of other research endeavors for use as biomarkers and methods to understand cancer susceptibility.

MTB’s mission is to plan, develop, direct, coordinate, and evaluate a comprehensive program of extramural research related to epidemiologic methods to:

  • address epidemiologic research issues and translate technological approaches developed in the context of other research endeavors to development of biomarkers of risk susceptibility and to cancer epidemiologic settings
  • translate paradigms and findings from basic biological sciences into epidemiologic studies and ensure that epidemiologic findings can be used to identify research directions in the basic sciences
  • improve epidemiologic study data collection, study designs, and analysis
  • assess the reliability and validity of methods and technologies for use in epidemiologic studies and ensure that these methods are sufficiently robust to use in epidemiologic data collection settings

It also disseminates findings from the research supported by the Branch to epidemiologists, the public, health care professionals, scientists engaged in cancer control, and the public health community.


Modifiable Risk Factors Branch

 
Britt Reid
Britt Reid, D.D.S., Ph.D.
Branch Chief
The Modifiable Risk Factors Branch (MRFB) focuses on factors that may be modifiable, such as diet and nutrition, alcohol, physical activity and energy balance, tobacco, infectious diseases, physical and chemical agents, and medical exposures including medications and treatments.

MRFB’s mission is to plan, develop, direct, coordinate, and evaluate:

  • a comprehensive program of extramural epidemiologic research in the etiology of cancer in human populations relating to factors that may be modifiable such as nutrition, physical activity and energy balance, infectious diseases, and physical and chemical agents
  • a program of extramural epidemiologic research to study differences in cancer susceptibility and risk in individuals and populations and the multiple environmental and genetic factors that jointly contribute to cancer, with the ultimate goal of elucidating the etiology of cancer
  • a program of extramural epidemiologic research to evaluate the association of and magnitude of cancer risk associated with biomarkers of exposure, biologically effective dose, and early damage
  • research resources, infrastructures, and consortia with a focus on modifiable risk factors to facilitate and maximize the scientific potential of cancer epidemiology research

Its mission is also to disseminate findings from the research supported by the Branch to the public, health care professionals, scientists engaged in cancer control, and the public health community.

 

Host Susceptibility Factors Branch

 
Elizabeth Gillanders
Elizabeth Gillanders, Ph.D.
Branch Chief
The Host Susceptibility Factors Branch (HSFB) focuses on personal susceptibility factors such as genetic, epigenetic, immunological and hormonal biological pathways, and social, cultural, and race/ethnic factors.

HSFB’s mission is to plan, develop, direct, coordinate, and evaluate:

  • a comprehensive program of epidemiologic research in the etiology of cancer in human populations related to host (i.e., personal) susceptibility factors such as genetic, epigenetic, immunological and hormonal biological pathways; and social, cultural, and race/ethnicity factors
  • a program of epidemiologic research to study differences in cancer susceptibility and risk in individuals and populations and the multiple environmental and genetic factors that jointly contribute to cancer, with the ultimate goal of elucidating the etiology of cancer
  • a program of extramural epidemiologic research to evaluate the association of and magnitude of cancer risk associated with biomarkers of host susceptibility such as physiological status or function
  • research resources, infrastructures, and consortia with a focus on personal susceptibility factors to facilitate and maximize the scientific potential of cancer epidemiology research

Its mission also is to disseminate findings from the research supported by the Branch to the public, health care professionals, scientists engaged in cancer control, and the public health community.

 
 

Clinical and Translational Epidemiology Branch

 
Debborah Winn
Deborah Winn, Ph.D.
Acting Branch Chief
The Clinical and Translational Epidemiology Branch (CTEB) focuses on clinical factors that influence development of cancer among persons with underlying diseases and conditions; the progression, recurrence, and mortality from cancer; and new primary cancers.

CTEB’s mission is to plan, develop, direct, coordinate, and evaluate:

  • a comprehensive program of epidemiologic research in human populations related to clinical factors that influence development of cancer among persons with underlying diseases and conditions and progression, recurrence, new primary cancers, and mortality from cancer among cancer survivors
  • a program of epidemiologic research to study differences in cancer susceptibility and risk in individuals and populations and the multiple environmental and genetic factors that jointly contribute to development of cancer among persons with underlying diseases and conditions and progression, recurrence, new primary cancers, and mortality from cancer among cancer survivors with the ultimate goal of elucidating cancer development and progression among people with these health conditions
  • a program of extramural epidemiologic research to evaluate the association of and magnitude of cancer risk associated with biomarkers of cancer development and progression in persons with underlying diseases and cancer
  • resources, infrastructures, and consortia with a focus on cancer development and progression in persons with underlying diseases and cancer to facilitate and maximize the scientific potential of cancer epidemiology research

Its mission also is to disseminate findings from the research supported by the Branch to the public, health care professionals, scientists engaged in cancer control, and the public health community.

 
The populations studied in the grants in CTEB are primarily patient populations—persons who have had cancer, have premalignant conditions or certain chronic or genetic diseases that may predispose to cancer, or have experienced certain treatments such as immunosuppression after organ transplants that may predispose to cancer.

Last modified:
09 Jan 2009
Search | Contact Us | Accessibility | Privacy Policy
  DCCPS National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal